Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $19,065 | 6 | 44.0% |
| Honoraria | $7,243 | 5 | 16.7% |
| Gift | $5,107 | 3 | 11.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $5,000 | 1 | 11.5% |
| Food and Beverage | $4,348 | 109 | 10.0% |
| Travel and Lodging | $2,494 | 10 | 5.8% |
| Education | $93.61 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. | $8,787 | 13 | $0 (2024) |
| Alimera Sciences, Inc. | $7,722 | 12 | $0 (2024) |
| Genentech, Inc. | $7,040 | 4 | $0 (2023) |
| Genentech USA, Inc. | $6,583 | 36 | $0 (2024) |
| Alcon Vision LLC | $6,215 | 6 | $0 (2023) |
| Carl Zeiss Meditec, Inc. | $5,107 | 3 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $956.92 | 29 | $0 (2024) |
| ABBVIE INC. | $238.45 | 10 | $0 (2024) |
| Apellis Pharmaceuticals, Inc. | $215.36 | 8 | $0 (2024) |
| Allergan, Inc. | $165.42 | 6 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $9,485 | 36 | Regeneron Pharmaceuticals, Inc. ($8,787) |
| 2023 | $13,030 | 25 | Genentech, Inc. ($7,040) |
| 2022 | $536.01 | 17 | Regeneron Healthcare Solutions, Inc. ($280.71) |
| 2021 | $3,390 | 10 | Genentech USA, Inc. ($2,052) |
| 2020 | $384.78 | 8 | Alimera Sciences, Inc. ($209.84) |
| 2019 | $12,858 | 19 | Alimera Sciences, Inc. ($6,270) |
| 2018 | $2,398 | 11 | Carl Zeiss Meditec, Inc. ($2,129) |
| 2017 | $1,267 | 9 | Carl Zeiss Meditec, Inc. ($848.28) |
All Payment Transactions
135 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $29.34 | General |
| Category: EYE CARE | ||||||
| 12/12/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $31.60 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/22/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Consulting Fee | Cash or cash equivalent | $2,896.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/22/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Consulting Fee | Cash or cash equivalent | $2,896.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/22/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Consulting Fee | Cash or cash equivalent | $1,448.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/21/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $32.94 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/17/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Travel and Lodging | In-kind items and services | $337.10 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/17/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $143.52 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/17/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $122.99 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/17/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $97.43 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/17/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $52.95 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/17/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $52.95 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/14/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Travel and Lodging | In-kind items and services | $186.60 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/11/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Travel and Lodging | In-kind items and services | $60.96 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/09/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $26.35 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/09/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: EYE CARE | ||||||
| 09/26/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Travel and Lodging | In-kind items and services | $457.48 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/26/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Travel and Lodging | In-kind items and services | $35.25 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/13/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $36.99 | General |
| 09/13/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $31.53 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/16/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $28.93 | General |
| Category: EYE CARE | ||||||
| 08/13/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $27.66 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/01/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $39.03 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/29/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $32.95 | General |
| Category: Ophthalmology | ||||||
| 07/15/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 6,724 | 40,072 | $13.9M | $5.1M |
| 2022 | 22 | 4,936 | 19,632 | $9.4M | $3.8M |
| 2021 | 19 | 4,539 | 17,755 | $7.9M | $3.3M |
| 2020 | 18 | 3,048 | 8,401 | $3.4M | $1.4M |
All Medicare Procedures & Services
86 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 280 | 3,162 | $4.0M | $2.2M | 54.6% |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | Office | 2023 | 178 | 3,646 | $2.7M | $800,317 | 30.0% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 70 | 18,900 | $1.3M | $545,859 | 41.3% |
| J3490 | Unclassified drugs | Office | 2023 | 140 | 307 | $863,200 | $417,367 | 48.4% |
| 67028 | Injection of drug into eye | Office | 2023 | 569 | 2,569 | $2.6M | $287,337 | 11.2% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 63 | 1,353 | $676,500 | $240,329 | 35.5% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 1,178 | 2,245 | $392,875 | $238,102 | 60.6% |
| 92134 | Imaging of retina | Office | 2023 | 1,450 | 3,924 | $490,500 | $132,862 | 27.1% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 582 | 924 | $115,500 | $66,200 | 57.3% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 258 | 258 | $52,280 | $30,606 | 58.5% |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | Office | 2023 | 12 | 182 | $91,000 | $28,709 | 31.5% |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | Office | 2023 | 11 | 180 | $79,200 | $21,665 | 27.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 159 | 159 | $34,980 | $21,011 | 60.1% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 141 | 142 | $24,850 | $16,571 | 66.7% |
| 92250 | Photography of the retina | Office | 2023 | 412 | 463 | $43,985 | $13,500 | 30.7% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 743 | 1,046 | $209,200 | $12,893 | 6.2% |
| 67036 | Removal of eye fluid (vitreous) between lens and retina | Facility | 2023 | 15 | 17 | $77,435 | $11,591 | 15.0% |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | Facility | 2023 | 11 | 11 | $50,105 | $10,434 | 20.8% |
| 67108 | Repair of detached retina with drainage and removal of eye fluid between lens and retina | Facility | 2023 | 11 | 11 | $50,105 | $10,338 | 20.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 141 | 147 | $22,050 | $9,680 | 43.9% |
| J7999 | Compounded drug, not otherwise classified | Office | 2023 | 30 | 106 | $10,600 | $7,736 | 73.0% |
| 92287 | Imaging of front third of eye using a special camera after injection of a dye | Office | 2023 | 49 | 49 | $9,800 | $6,109 | 62.3% |
| 67145 | Photocoagulation treatment to prevent detachment of retina | Office | 2023 | 16 | 17 | $27,200 | $3,500 | 12.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 30 | 31 | $5,270 | $3,180 | 60.3% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 48 | 75 | $16,650 | $2,963 | 17.8% |
About Dr. Daniel Learned, M.D
Dr. Daniel Learned, M.D is a Ophthalmology healthcare provider based in Santa Barbara, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/01/2011. The National Provider Identifier (NPI) number assigned to this provider is 1033406780.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Learned, M.D has received a total of $43,350 in payments from pharmaceutical and medical device companies, with $9,485 received in 2024. These payments were reported across 135 transactions from 16 companies. The most common payment nature is "Consulting Fee" ($19,065).
As a Medicare-enrolled provider, Learned has provided services to 19,247 Medicare beneficiaries, totaling 85,860 services with total Medicare billing of $13.5M. Data is available for 4 years (2020–2023), covering 86 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Other Specialties Ophthalmology, Ophthalmology
- Location Santa Barbara, CA
- Active Since 07/01/2011
- Last Updated 07/21/2022
- Taxonomy Code 207W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1033406780
Products in Payments
- EYLEA HD (Biological) $9,005
- Vabysmo (Drug) $7,350
- Iluvien (Drug) $6,480
- Lucentis (Biological) $6,218
- VISULAS 532s (Device) $5,107
- ILUVIEN (Drug) $1,219
- EYLEA (Biological) $544.16
- OZURDEX (Drug) $305.38
- EYLEA AFLIBERCEPT INJECTION (Biological) $194.52
- Syfovre (Drug) $190.74
- Constellation (Device) $53.30
- ForeseeHome (Device) $43.18
- LUMIGAN (Drug) $32.51
- Izervay (Drug) $27.17
- VABYSMO (Drug) $24.90
- DEXYCU (Drug) $23.90
- YUTIQ (Drug) $23.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Santa Barbara
Dr. Nathan Steinle, M.d, M.D
Ophthalmology — Payments: $1.2M
Dr. Douglas Katsev, Md, MD
Ophthalmology — Payments: $825,853
Michael Paveloff, Md, MD
Ophthalmology — Payments: $40,714
Dr. Stephen Couvillion, Md, MD
Ophthalmology — Payments: $27,316
Dr. Stuart Winthrop, M.d, M.D
Ophthalmology — Payments: $5,752
Dr. Robert Poulin, M.d, M.D
Ophthalmology — Payments: $4,450